Good news. I know punters were looking for early end. But at only 30% complete, it's a decision IMO for long term assurance these results will stand without question. FDA does not like trials with a small number of results.
My take is they have probably completed the vast majority of enrolments but the time now is to wait for the 30 day all cause mortality on these enrolments so the next 60% read out could be very soon.
Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial, page-58
-
- There are more pages in this discussion • 242 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |